| Period Ending: |
LTM
(Last Twelve Months) |
2023 12-31 |
2022 12-31 |
|---|---|---|---|
| Report Filing | 2024-04-16 | 2023-03-31 | |
| Revenue | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | |
| Operating Expenses | 0.68 | 0.08 | |
| Research & Development | 0.00 | 0.00 | |
| Selling, General and Administrative | 0.68 | 0.08 | |
| Other Operating Expenses | 0.00 | 0.00 | |
| Operating Income | -0.68 | -0.08 | |
| Net Non-Operating Interest | 0.00 | 0.04 | |
| Interest Income | 0.00 | 0.04 | |
| Interest Expense | 0.00 | 0.00 | |
| Equity & Other Income/(Expense) | 3.58 | 0.00 | |
| Income Before Tax | 2.90 | -0.04 | |
| Income Tax Expense | 0.00 | 0.00 | |
| Income Attributable to Non-Controlling Interest | 0.00 | 0.00 | |
| Net Income | 2.90 | -0.04 | |
| Depreciation and Amortization | 3.58 | 0.08 | |
| EBITDA | 2.90 | 0.00 | |
| Earnings Per Share (EPS) | 0.320 | -0.005 | |
| Diluted Earnings Per Share | 0.320 | -0.005 | |
| Weighted Average Shares Outstanding | 9.15 | 9.18 | |
| Diluted Weighted Average Shares Outstanding | 9.15 | 9.18 |
